Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-7005
Abstract: 1.Background: Acute myeloid leukemia (AML) remains a challenging hematologic malignancy with heterogeneous genetic and clinical features. BCOR and BCORL1 mutations, occurring in approximately 3-5%[1] of AML cases, have been classified as adverse prognostic markers together… read more here.
Keywords: reached ccr; cohort; bcor bcorl1; treatment ... See more keywords